IL6 and bronchial disorder: These factors induce the release of pro-inflammatory cytokines, such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), amplifying airway inflammation and increasing the likelihood of bronchospasm, laryngospasm, and other RAEs.[25]